S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

SUPN Supernus Pharmaceuticals Inc

37.195

-0.865 (-2.27%)

Last Updated: 10:53:05

Delayed by 15 minutes

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

null

Supernus Pharmaceuticals (NASDAQ:SUPN)
Historical Stock Chart
From Dec 2024 to Jan 2025

Click Here for more Supernus Pharmaceuticals Charts.

Supernus Pharmaceuticals (NASDAQ:SUPN)
Historical Stock Chart
From Jan 2024 to Jan 2025

Click Here for more Supernus Pharmaceuticals Charts.

Supernus Pharmaceuticals Inc News

Form 4 - Statement of changes in beneficial ownership of securities
Monday 30 December 2024 (2 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 30 December 2024 (2 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 26 December 2024 (2 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 26 December 2024 (2 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 20 December 2024 (3 weeks ago) • Edgar (US Regulatory)

Knight Therapeutics Announces Filing of New Drug Submission for Qelbree® (viloxazine) in Canada
Monday 16 December 2024 (4 weeks ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 4 December 2024 (1 month ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Tuesday 3 December 2024 (1 month ago) • Edgar (US Regulatory)

Supernus to Participate in the 36th Annual Piper Sandler Healthcare Conference
Tuesday 26 November 2024 (1 month ago) • GlobeNewswire Inc.

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Thursday 14 November 2024 (2 months ago) • Edgar (US Regulatory)

Supernus Pharmaceuticals to Participate in the 2024 Jefferies London Healthcare Conference
Wednesday 13 November 2024 (2 months ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 12 November 2024 (2 months ago) • Edgar (US Regulatory)

More Supernus Pharmaceuticals Inc News Articles

Deutsche Boerse (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions